A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability

The retinoblastoma (RB) gene is one of the most extensively studied tumour-suppressor genes(1). Deletion or inactivation of both RE alleles is an essential, rate-limiting step in the formation of retinoblastoma and osteosarcoma that arise in families that carry mutant RE (ref. 2). RE inactivation is also found in other human tumours(3-8). Whereas loss of RE function is associated with the loss of cellular proliferative control, introduction of a wild-type RE can suppress cell growth and tumorigenicity(5,9-12). Thus, identification of factors that interfere with and/or control the function of the RE protein is critical for understanding both cell-cycle control and oncogenesis. Here we describe a new gene, Bog (for B5T over-expressed gene), which was identified and shown to be overexpressed in several transformed rat liver epithelial (RLE) cell lines resistant to the growth-inhibitory effect of TGF-beta 1, as well as in primary human liver tumours. The Bog protein shares homology with other retinoblastoma-binding proteins and contains the Rb-binding motif LXCXE. Using the yeast two-hybrid system and co-immunoprecipitation. we demonstrated that Bog binds to Rb. In vivo, Bog/Rb complexes do not contain E2F-1, and Bog can displace E2F-1 from E2F-1/Rb complexes in vitro. Overexpression of Bog in normal RFE cells conferred resistance to the growth-inhibitory effect of TGF-beta 1. Furthermore, normal RLE cells are rapidly transformed when Bog is continuously overexpressed and form hepatoblastoma-like tumours when transplanted into nude mice. These data suggest that Bog may be important in the transformation process, in part due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta 1 through interaction with Rb and the subsequent displacement of E2F-1.